Early Blood Pressure Targets in Acute Spinal Cord Injury: A Randomized Clinical Trial
1. Early augmented blood pressure management did not result in better neurological recovery compared with conventional blood pressure management at ...
1. Early augmented blood pressure management did not result in better neurological recovery compared with conventional blood pressure management at ...
1. In this randomized controlled trial, hypotension- and hypertension-avoidance strategies yielded similar post-operative delirium frequency and severity following non-cardiac surgery. ...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this randomized controlled trial, patients with stroke symptoms who were given antihypertensives en route to the hospital did ...
1. A significant reduction in all-cause mortality was seen among patients in the intervention group compared to usual care. 2. ...
1. In this sham-controlled, randomized clinical trial, among 224 patients with hypertension, ultrasound renal denervation demonstrated clinically relevant reductions in ...
1. Compared to placebo, participants on aprocitentan had a greater reduction in office systolic blood pressure at four weeks and ...
1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability ...
1. Patients assigned to renal artery denervation had significantly lower office and ambulatory blood pressures at 36-month follow-up compared to ...
1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.